» Articles » PMID: 38416324

Low Temperature Vaporized Hydrogen Peroxide Sterilization of 3D Printed Devices

Overview
Journal 3D Print Med
Publisher Biomed Central
Date 2024 Feb 28
PMID 38416324
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Low temperature vaporized hydrogen peroxide sterilization (VH2O2) is used in hospitals today to sterilize reusable medical devices. VH2O2 sterilized 3D printed materials were evaluated for sterilization, biocompatibility and material compatibility.

Materials & Methods: Test articles were printed at Formlabs with BioMed Clear™ and BioMed Amber™, and at Stratasys with MED610™, MED615™ and MED620™. Sterilization, biocompatibility and material compatibility studies with 3D printed materials were conducted after VH2O2 sterilization in V-PRO™ Sterilizers. The overkill method was used to evaluate sterilization in a ½ cycle. Biocompatibility testing evaluated the processed materials as limited contact (< 24-hours) surface or externally communicating devices. Material compatibility after VH2O2 sterilization (material strength and dimensionality) was evaluated via ASTM methods and dimensional analysis.

Results: 3D printed devices, within a specific design window, were sterile after VH2O2 ½ cycles. After multiple cycle exposure, the materials were not cytotoxic, not sensitizing, not an irritant, not a systemic toxin, not pyrogenic and were hemo-compatible. Material compatibility via ASTM testing and dimensionality evaluations did not indicate any significant changes to the 3D printed materials after VH2O2 sterilization.

Conclusion: Low temperature vaporized hydrogen peroxide sterilization is demonstrated as a suitable method to sterilize 3D printed devices. The results are a subset of the data used in a regulatory submission with the US FDA to support claims for sterilization of 3D printed devices with specified materials, printers, and device design .

Citing Articles

Advancing Surgical Arrhythmia Ablation: Novel Insights on 3D Printing Applications and Two Biocompatible Materials.

Monaco C, Kronenberger R, Talevi G, Pannone L, Cappello I, Candelari M Biomedicines. 2024; 12(4).

PMID: 38672223 PMC: 11048352. DOI: 10.3390/biomedicines12040869.

References
1.
George E, Liacouras P, Rybicki F, Mitsouras D . Measuring and Establishing the Accuracy and Reproducibility of 3D Printed Medical Models. Radiographics. 2017; 37(5):1424-1450. PMC: 5621728. DOI: 10.1148/rg.2017160165. View

2.
Shea G, Wu K, Li I, Leung M, Ko A, Tse L . A review of the manufacturing process and infection rate of 3D-printed models and guides sterilized by hydrogen peroxide plasma and utilized intra-operatively. 3D Print Med. 2020; 6(1):7. PMC: 7106677. DOI: 10.1186/s41205-020-00061-w. View

3.
Horst A, McDonald F, Hutmacher D . A clarion call for understanding regulatory processes for additive manufacturing in the health sector. Expert Rev Med Devices. 2019; 16(5):405-412. DOI: 10.1080/17434440.2019.1609353. View

4.
Shaheen E, Alhelwani A, Van de Casteele E, Politis C, Jacobs R . Evaluation of Dimensional Changes of 3D Printed Models After Sterilization: A Pilot Study. Open Dent J. 2018; 12:72-79. PMC: 5815034. DOI: 10.2174/1874210601812010072. View

5.
Ricles L, Coburn J, Di Prima M, Oh S . Regulating 3D-printed medical products. Sci Transl Med. 2018; 10(461). DOI: 10.1126/scitranslmed.aan6521. View